Characterization of transgenic mice expressing Apolipoprotein E4(C112R) and Apolipoprotein E4(L28P; C112R)
- 1 October 2000
- journal article
- Published by Elsevier in Neuroscience
- Vol. 101 (1) , 211-218
- https://doi.org/10.1016/s0306-4522(00)00341-9
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's diseaseNeuroscience Letters, 1999
- Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosisAtherosclerosis, 1998
- Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levelsHuman Mutation, 1994
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Apolipoprotein E polymorphism and atherosclerosis.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- Abnormal in vivo metabolism of apolipoprotein E4 in humans.Journal of Clinical Investigation, 1986
- Expression of apolipoprotein E during nerve degeneration and regeneration.Proceedings of the National Academy of Sciences, 1986
- Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system.Journal of Clinical Investigation, 1985
- Apolipoprotein E synthesis in human kidney, adrenal gland, and liver.Proceedings of the National Academy of Sciences, 1983
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981